Peptides are everywhere in skincare right now. Serums, creams, collagen powders, even injections sold online.
The promise is simple: smoother, firmer, younger-looking skin.
But do peptides for skin actually work? Or is it clever marketing?
The research gives a clear, if unglamorous, answer. Some peptides produce modest improvements, mostly the ones you swallow.
The injectable kind sold online has almost no human evidence at all.
Here’s what the trials show.
- A 2026 review of 19 trials found peptides modestly improved skin hydration, brightness and wrinkles, mostly from oral forms.
- Collagen supplements improved skin hydration and elasticity in a separate review, but most studies were small.
- Injectable peptides like BPC-157 have no controlled human trials, and the FDA says it lacks the data to know whether they’re harmful.
Do peptides for skin work?
The short answer: some do, a little.
Peptides are short chains of amino acids, the building blocks of proteins like collagen. In skincare, they’re used in two main ways.
Some are applied to the skin, in creams and serums. Others are swallowed, usually as collagen peptide supplements.
The best evidence suggests oral collagen peptides can modestly improve skin hydration and elasticity. Creams have weaker evidence.
And injectable “research peptides” are largely untested in people.
Before any of that, one thing matters more. The US National Institute on Aging calls the sun “another major contributor to skin aging”.
It also advises: “Be skeptical about products that claim to be antiaging or able to reduce wrinkles.”
The reason is striking. Many of these products count as cosmetics, not drugs, “so they are not required to be tested in humans”.
They also don’t need approval from the US Food and Drug Administration before they go on sale.
The institute adds that some “may contain heavy metals such as mercury and lead”.
The biggest recent review
What it looked at
In March 2026, researchers published a systematic review and meta-analysis in Frontiers in Medicine. It pooled randomised controlled trials of peptides for skin aging.
They analysed 19 trials involving 1,341 participants. Seventeen tested peptides taken by mouth, and just two tested creams.
Every trial was double-blind and placebo-controlled. Treatments lasted between four and 12 weeks.
Placebos included capsules of maltodextrin or cellulose, or an identical base cream without the peptide. Participants ranged from their early 20s to their mid-80s.
What it found
The review found that peptides, “particularly oral formulations, significantly improved hydration and brightness”.
For wrinkles, the effect was smaller. The pooled result was “a modest pooled effect on wrinkle reduction”, driven “largely” by oral polypeptides.
| Skin measure | What the review found |
|---|---|
| Hydration | Significantly improved, mainly with oral peptides |
| Brightness | Significantly improved |
| Wrinkles | A modest improvement, mostly from oral peptides |
| Elasticity and density | Inconsistent results |
| Side effects | Minimal, peptides were well tolerated |
In a subgroup comparison, “oral peptides outperformed topical formulations across most outcomes.”
The trials also varied enormously. The review reported very high heterogeneity, which it put down to differences in “peptide type, dose, and assessment methods”.
The authors concluded that “peptides appear to be safe, non-invasive anti-aging agents”. But they called for “larger RCTs with standardized outcomes”.
Peptides can modestly improve skin hydration and wrinkles, mostly when taken by mouth. The effects are real but small, and the trials behind them are mostly small too.
Collagen supplements: the strongest evidence
What the trials show
Collagen peptide supplements are the most studied peptide product for skin.
A 2025 review in the Indian Journal of Dermatology, Venereology and Leprology pooled 10 randomised trials with 646 participants. The studies ran from 2010 to 2021.
It found collagen supplements “were statistically effective in increasing skin hydration” and elasticity.
| Measure | Effect size (standardised) | Rough size |
|---|---|---|
| Skin hydration | 1.25 | A large effect |
| Skin elasticity | 0.61 | A moderate effect |
The most common dose was 4 grams a day. Doses in the studies ranged from 1 to 10 grams a day.
What a typical trial looks like
The trials behind these reviews are small. In one Brazilian trial in the 2026 review, 114 women took collagen peptides made from pig skin, or a placebo.
After four and eight weeks, the peptide group had around 20% less wrinkle volume around the eyes than the placebo group.
In a US trial of 113 women, hydrolysed collagen significantly reduced facial lines and crow’s feet.
That’s typical of this research: a few dozen to about a hundred people, mostly women, followed for a few weeks.
The limits
The authors were candid. “The risk of bias was generally unclear”, and there were too few studies to check for publication bias.
The findings also apply mainly to women, who made up most participants. And most studies couldn’t control for the weather, which affects skin hydration.
Peptide creams and serums
What we know
Topical peptides include copper peptides (GHK-Cu) and “signal peptides” sold under trade names such as Argireline and Matrixyl.
In the 2026 review, only two of the 19 trials tested creams. That alone limits what we can say about them.
A 2026 systematic review of the copper peptide GHK-Cu, in Archives of Internal Medicine Research, is revealing. Its authors screened 1,247 records published between 2005 and 2026, and kept 64 for their analysis.
They found “more than four decades of pre-clinical evidence”, mostly from lab and animal studies.
But “the clinical literature in humans remains thin and fragmented”. Most human trials “are small, conducted on facial cosmetic creams”.
Why creams may do less
The skin’s outer layer is a strong barrier. The GHK-Cu review notes that few trials use delivery methods “capable of reliably crossing” it.
That may be one reason creams show weaker results than supplements in the pooled trials.
Injectable peptides: the risky trend
What’s being sold
Online, a different kind of peptide is booming: injectable “research peptides”. One of the most popular is BPC-157, promoted for healing and recovery.
These are a world away from skincare creams. And the evidence is far thinner.
Almost no human evidence
A September 2026 review in the International Journal of Molecular Sciences examined BPC-157 research, searching studies up to 24 June 2026. It found the evidence comes from rodent studies.
It concluded that BPC-157 is “a hypothesis-generating investigational candidate” rather than “an established therapy”. It said “controlled human studies would be required before clinical translation could be considered.”
What regulators say
The US Food and Drug Administration lists BPC-157 among bulk substances for compounding that may present significant safety risks.
It says compounded BPC-157 “may pose risk for immunogenicity for certain routes of administration”. It adds that the agency “lacks sufficient information to know whether the drug would cause harm when administered to humans.”
In July 2026, an FDA advisory committee reviewed BPC-157 for use in compounding. The FDA’s evaluation “weighed against” allowing it, according to the 2026 review.
BPC-157 is also on the World Anti-Doping Agency’s 2026 Prohibited List, as a non-approved substance.
What earlier research found
The source of the collagen idea
The collagen idea is simple. The National Institute on Aging explains how ageing skin changes.
Losing elastin and collagen makes skin “look older, develop wrinkles, and be more fragile”.
Supplements versus creams
In its subgroup analysis, the 2026 peptide review found oral peptides did better than creams on most outcomes. The 2025 collagen review, which looked only at supplements, found improvements in hydration and elasticity.
Together, they point in the same direction for oral collagen.
How it fits together
Oral collagen peptides have the most consistent evidence, though it’s modest. Creams are less proven.
Injectable peptides are essentially untested in people.
How much should you trust this?
Early. There are real, measurable benefits for some peptides. But the trials are small, short and often of unclear quality.
What makes it convincing
- Two separate systematic reviews point the same way for oral collagen.
- The reviews pooled randomised controlled trials, the strongest study design.
- Side effects were minimal in the pooled trials.
What makes me cautious
- Most trials are small and short, often a few months.
- Risk of bias was “generally unclear” in the collagen review.
- Products, doses and outcome measures vary widely between trials.
- The review abstracts don’t report who funded the individual trials, so industry influence can’t be ruled out.
- In the 2026 review, blinding of assessors was often unclear, and some trials lost many participants.
- Injectable peptides have no controlled human trials at all.
| The evidence shows | The evidence does not show |
|---|---|
| Oral collagen peptides can modestly improve hydration | That peptides reverse ageing |
| Peptides were well tolerated in trials | That every peptide cream works |
| Wrinkle improvements were small | That results last after you stop |
| BPC-157 has only rodent evidence | That injectable peptides are safe or effective |
What this means for you
- Protect your skin from the sun first. It’s one of the biggest drivers of skin aging.
- Collagen supplements may help a little. Trials used around 1 to 10 grams a day. Expect modest changes, not a transformation.
- Be realistic about creams. Some may help, but the human evidence is thinner.
- Avoid injectable “research peptides”. The FDA says it lacks the data to know whether BPC-157 would harm people.
- Talk to a dermatologist about proven options, especially if you have a skin condition. The National Institute on Aging recommends seeing “a doctor specially trained in skin problems” for advice.
The National Institute on Aging guide to skin care and aging is a practical, balanced read.
In this short Mayo Clinic video, experts discuss whether collagen supplements can help with aging:
What we still don’t know
- Do the benefits last? Most trials are too short to tell.
- Which peptides work best? Products vary too much to compare fairly.
- Do creams get through the skin? Better delivery methods are still being tested.
- Are injectable peptides safe? There’s no controlled human evidence.
- Who benefits most? Most collagen trials involved women.
My take: modest help, big claims
What I like about the collagen research is that it’s been tested properly, in randomised trials. There’s a real, if small, benefit.
I’m less convinced by the marketing. “Anti-aging” peptides don’t turn back the clock. The best evidence shows modest gains in hydration and wrinkles.
And I’d stay well away from injectable peptides bought online. The science simply isn’t there, and regulators are worried for good reason.
Last reviewed: 2026-09-30
Covers: Whether peptides for skin work, collagen supplements, peptide creams and serums, and injectable peptides like BPC-157
Evidence: Early — small, real benefits in trials, mostly from oral collagen; no controlled human trials of injectable peptides
Comments
No comments yet. What did you think?